🇺🇸 FDA
Patent

US 9320786

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

granted A61KA61K31/42A61K31/422

Quick answer

US patent 9320786 (Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/42, A61K31/422, A61K31/423, A61K31/427